Skip to main content
Signal8

Sinha Vikas

SEC insider (Form 3/4/5 filer). CIK 0001337845. Chief Financial Officer at Scholar Rock Holding Corp (SRRK) and 2 other issuers. 31 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2026. Located in CAMBRIDGE, MA.

Companies Sinha Vikas has filed insider reports for

  • Scholar Rock Holding Corp (SRRK): Officer, Chief Financial Officer
  • Verona Pharma plc (VRNA): Director
  • Allovir, Inc. (ALVR): Director, Officer, 10% Owner, See Remarks
Sinha Vikas profile photo

Sinha Vikas

CIK: 0001337845

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (54.8%)

Position reduction

Option Exercises (M)7 (22.6%)

Derivative conversions

Awards (A)5 (16.1%)

Compensation grants

Other (G, F, J, C, D, …)2 (6.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Scholar Rock Holding Corp logo
SRRK

Scholar Rock Holding Corp

Officer
Verona Pharma plc logo
VRNA

Verona Pharma plc

Director
Allovir, Inc. logo
ALVR

Allovir, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (31 total)

  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Apr 16, 2026
    Sale
    Direct
    10.4K shares at avg. $49.57$516K
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Feb 9, 2026
    Award
    Direct
    47K shares-
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Jan 13, 2026
    Sale
    Direct
    16.8K shares at avg. $42.70$715K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    72K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    94.1K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Exercise
    Direct
    72K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Exercise
    Direct
    24K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Sale
    Direct
    4.3K shares at avg. $13.14$57K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    May 20, 2025
    Sale
    Direct
    160K shares at avg. $9.39$1.5M
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    May 20, 2025
    Exercise
    Direct
    160K shares at avg. $0.50$81K

1-10 of 31